Vassilios Papadopoulos

Executive Director and Chief Scientific Officer, Research Institute of the McGill University Health Centre (RI-MUHC)






Vassilios Papadopoulos, D.Pharm, Ph.D, is a Professor in the Faculty of Medicine at McGill University and holds a Canada Research Chair in Biochemical Pharmacology and the Phil Gold Chair in Medicine at McGill and the MUHC. His research focus is in the pathophysiology and treatment of diseases related to altered steroid hormone synthesis, including endocrine pathologies, male reproductive disorders, neuropathologies and cancer. He has published over 280 papers, holds numerous patents and serves on advisory committees of various U.S., Canadian, European and other government agencies, foundations and corporations. He is an elected member of the National Academies of Medicine and Pharmacy in France, a fellow of the American Association for the Advancement of Science in the United States, and a fellow of the Canadian Academy of Health Sciences.

Related Articles